Letter

Harmful impact of EU clinical trials directive: …while paediatric oncology is being scuppered

BMJ 2006; 332 doi: 10.1136/bmj.332.7542.666-b (Published 16 March 2006)
Cite this as: BMJ 2006;332:666.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Christopher D Mitchell, consultant paediatric oncologist (chris.mitchell@paediatrics.ox.ac.uk)
  1. John Radcliffe Hospital, Oxford OX3 9DU

    EDITOR—The editorial by Hemminki and Kellokumpu-Lehtinen is a startling summary of the impact of the EU Clinical Trials Directive and the associated national legislation on the conduct of investigator led research.1 It is remarkable how little response or debate has emerged since the introduction of this directive: every investigator …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular